Clinical trial · Interventional
Evaluation of the Effects of Equicoaching on Social Reintegration Among Young Adults Who Have Been Treated for Cancer
NCT07515274CI-TRIAL-00108036EQUICAPnot yet recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a category 2 human research study (RIPH), interventional, single-center, prospective, open-label. The primary objective of this study is to qualitatively assess the effects of equicoaching on social reintegration in young adults who have been treated for cancer. The secondary objectives are to evaluate the contribution of equicoaching to: 1. Self-confidence; 2. Well-being 3. Quality of life Satisfaction with equicoaching will also be evaluated.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer Pediatric | Malignant Neoplasm | ALIAS | 0.85 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| equicoaching | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- intervention EQUICAP
- interventionNames
- Procedure: equicoaching
Primary outcomes (1)
- measure
- social reintegration
- timeFrame
- Inclusion and month 6
- description
- Social reintegration will be assessed using a qualitative comparative analysis of two individual semi-structured interviews conducted at baseline and six months after the intervention. Interview topics will include illness trajectory, social and family relationships, level of autonomy and independence, ability to plan for the future, social participation, and participants' perceptions of the equicoaching intervention. All interviews will be audio-recorded, transcribed verbatim, and analyzed using thematic analysis with NVivo software to identify changes in themes and subthemes over time.
Secondary outcomes (3)
- measure
- Self-confidence
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 15 Years
- Maximum age
- 25 Years
Show eligibility criteria text
Inclusion Criteria: * Have been treated for a malignant oncological or hematological condition. * Be between 15 and 25 years of age at the time of cancer diagnosis. This age range corresponds to that chosen by the Leon Berard Cancer Center (CLB) and the Institute of Pediatric Hematology and Oncology (IHOPe) for the Adolescents and Young Adults with Cancer (DAJAC) program * Have been treated at IHOPe/CLB as part of the DAJAC program * Have completed intensive treatment within the last twelve months. * Be able to understand, read, and write French * Be affiliated with a health insurance plan * Have been informed about the study and have given consent For minors: * All of the above criteria * Parent/legal guardian informed about the study and having given consent Exclusion Criteria: * Patient deprived of liberty by judicial or administrative decision * Pregnant or breastfeeding women
References
Publications (0)
Data not yet available
No reference posted for this study.